The designation supports priority engagement with the FDA as Portal Diabetes advances clinical trials and regulatory submissions.

Portal Diabetes announced today that it received FDA breakthrough device designation for its implantable insulin pump system.

Today, Portal Diabetes, Inc. ("Portal") announced its receipt of the Breakthrough Device Designation by the Food and Drug ...

Portal Diabetes has received Breakthrough Device Designation by the Food and Drug Administration (FDA) for its implantable ...

An innovative insulin implant could redefine the future of diabetes management. Here's how this breakthrough diabetes treatment works, its benefits, risks, and what it means for people living with ...

Chinese scientists have achieved the world's first reversal of type-2 diabetes using stem-cell therapy. Here is what you need to know about the breakthrough and why it matters for the world and for ...

BUFFALO, N.Y. ­­— Jun Qu, professor of pharmaceutical sciences at the University at Buffalo, and researchers in his lab have made a significant breakthrough in diagnosing and classifying Type 1 ...

Breakthrough T1D, formerly known as JDRF, will host a Southeast Michigan Community Summit in March, aiming to raise awareness ...

A breakthrough in insulin delivery could one day spell an end to the invasive needles on which many people with diabetes rely. Using mice, minipigs, and lab-grown human skin samples, scientists have ...

"The State of T1D" is a Comprehensive Resource for Type 1 Diabetes, Developed to Make Accurate Statistics and Information about the Autoimmune Condition More Accessible As part of the organization's ...